spacer
home > epc > autumn 2008 > the bpo boom
PUBLICATIONS
European Pharmaceutical Contractor

The BPO Boom

There’s nothing like a darkening economic climate and rising competitive pressures to focus a business’ priorities, and few industries are being spared this experience at the moment. Like their counterparts in other commercial sectors, pharmaceutical organisations are being forced to re-examine their core and non-core activities in order to determine where new efficiencies can be found, and to drive greater productivity and competitive agility into their operations. This is leading to a surge of interest in the outsourcing of non-core activities, as pharma organisations attempt to sharpen their practices and reduce time to market.

Fortunately, as these organisations are discovering, there has been an increase in the availability and scope of managed services being offered by external specialists, which now include partial or complete outsourcing of regulatory submission operations.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Adam Sherlock is ISI’s Managing Director/Vice President Europe. During a career that spans some 20 years in the IT industry, Adam has served in senior director roles in a number of life sciences-focused organisations, including IQ Consultancy, the Synapse Partnership and medical communications agency, Gardner Caldwell. Adam was awarded his honours degree in Applied Microbiology from Liverpool University.
spacer
Adam Sherlock
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Innovative Micro-Infusion Pump for Gerresheimer Subsidiary Sensile Medical Developed and Successfully Launched for EVER Pharma

Düsseldorf/Olten, July 03, 2019 – Developed specially by Sensile Medical for EVER Pharma under the brand name D-mine®, this wearable microinfusion pump recently received European CE certification and has already been launched in several European countries. The compact, patient-friendly infusion pump is used for the continuous subcutaneous administration of drugs to treat Parkinson’s disease. The first micro pump from Gerresheimer subsidiary Sensile Medical to be available on the market, it gives Parkinson’s patients greater independence in their day-today lives.
More info >>

White Papers

Clinical Trial Site Contracting: The Conservative, Progressive and Hybrid Models

DrugDev

For the last 20 years, pharmaceutical companies have turned to a variety of clinical outsourcing solutions to reduce costs and improve timelines, enabling them to focus on their core value of research and development. In today’s tightly competitive market, companies are constantly striving for ways to further cut costs and reduce study startup cycle times, while maintaining quality. One of the key cost factors in global R&D spending, estimated at around $102 billion per Kalorama market research, is the cost of conducting clinical trials. CRO’s, which account for about 30% of the total R&D spending, have risen to the challenge of the clinical, technical and administrative management of these trials. But some pharmaceutical companies question how much control to relinquish to vendor partners, especially in the legal arena, due to potential ramifications.
More info >>

 
Industry Events

Nordic Life Science Days 10/12 September 2019

10-12 September 2019, Malmo Sweden

Nordic Life Science Days is the largest Nordic partnering conference for the global Life Science industry. Bringing together the best talents in Life Science, offering amazing networking and partnering opportunities, providing inputs and content on the most recent trends. Nordic Life Science Days attracts leading decision makers from the Life Science sector, not only from biotech, pharma and medtech but also from finances, research, policy and regulatory authorities.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement